The Board sent shockwaves through employment law in its February 21, 2023, decision in Mclaren Macombwhich held that simply offers a draft settlement agreement with broad confidentiality and non-disparagement provisions violated the National Labor Relations Act (“NLRA”). We previously
Now on Spilling Secrets, our podcast series on the future of non-compete and trade secret law:
The 2023 Academy Awards are over, but we’re keeping the awards season alive with our very own Trade Secrets Fail Awards, highlighting Hollywood’s biggest …
Los Angeles, California–(Newsfile Corp. – March 15, 2023) – The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fate Therapeutics, Inc. (“Fate” or “the Company”) FATE for violations of §§10(b) and
NEW YORK, March 12, 2023 /PRNewswire/ —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ESS Tech Inc. (NYSE:GWH) between August 11, 2022 and December 7, 2022both dates inclusive (the
New York, New York–(Newsfile Corp. -February 26, 2023) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sotera Health Company SHC: (i) pursuant and/or traceable to the Company’s initial public offering
Thomson Reuters Practical Law has released the 2023 update to “Trade Secrets Litigation,” co-authored by our colleague Peter A. Steinmeyer.
Following is an excerpt (see below to download the full article in PDF format):
Trade secrets are often an employer’s …
Welcome to the third annual installment of Seyfarth Shaw’s Commercial Litigation Outlook, in which our nationally-recognized team provides insights about litigation issues and trends to expect in 2023.
The likely continuing global tumult and increasing chances for a recession will
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PLDT Inc. (“PLDT” or “the Company”) PHI for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule
NEW YORK, Feb. 2, 2023 /PRNewswire/ —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Bioventus Inc. (NASDAQ: BVS): (i) pursuant and/or traceable to the offering documents issued in connection with
